中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 8
Aug.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(8): 1934-1937

Advances in the application of endoscopic ultrasound in the diagnosis and treatment of liver cancer

DOI: 10.3969/j.issn.1001-5256.2021.08.041
  • a.

    Center of Minimally Invasive Diagnosis and Treatment of Hepatobiliary, Pancreatic and Splenic Surgery, The Affiliated Yantai Hospital of Binzhou Medical University, Yantai, Shandong 264100, China

  • b.

    Department of Hepatobiliary, Pancreatic and Splenic Surgery, The Affiliated Yantai Hospital of Binzhou Medical University, Yantai, Shandong 264100, China

  • Received Date: 2021-01-02
  • Accepted Date: 2021-02-01
  • Published Date: 2021-08-20
    Abstract
  • Liver cancer is one of the most common malignant tumors in China, and its incidence rate is increasing year by year. Therefore, the early diagnosis and treatment of liver cancer is of great importance. Among various examinations, endoscopic ultrasound (EUS) can perform close scanning of the liver and the biliary system, which plays an indispensable role in the diagnosis, treatment, and staging of liver cancer. This article reviews the current status and future perspectives of EUS in the diagnosis and treatment of liver cancer, in order to provide a reference for the clinical diagnosis and treatment of liver cancer.

     

    • FullText(HTML)
  • loading
    • References(46)
  • [1]
    WU M, LIU Z, LI X, et al. Dynamic changes in serum markers and their utility in the early diagnosis of all stages of hepatitis B-associated hepatocellular carcinoma[J]. Onco Targets Ther, 2020, 13: 827-840. DOI: 10.2147/OTT.S229835.
    [2]
    HENNEDIGE T, VENKATESH SK. Imaging of hepatocellular carcinoma: Diagnosis, staging and treatment monitoring[J]. Cancer Imaging, 2013, 12: 530-547. DOI: 10.1102/1470-7330.2012.0044.
    [3]
    SINGH P, MUKHOPADHYAY P, BHATT B, et al. Endoscopic ultrasound versus CT scan for detection of the metastases to the liver: Results of a prospective comparative study[J]. J Clin Gastroenterol, 2009, 43(4): 367-373. DOI: 10.1097/MCG.0b013e318167b8cc.
    [4]
    ICHIM VA, CHIRA RI, MIRCEA PA, et al. Accuracy of endoscopic ultrasound-guided biopsy of focal liver lesions[J]. Med Ultrason, 2020, 22(1): 20-25. DOI: 10.11152/mu-2078.
    [5]
    SINGH P, ERICKSON RA, MUKHOPADHYAY P, et al. EUS for detection of the hepatocellular carcinoma: Results of a prospective study[J]. Gastrointest Endosc, 2007, 66(2): 265-273. DOI: 10.1016/j.gie.2006.10.053.
    [6]
    LANGE A, MUNIRAJ T, ASLANIAN HR. Endoscopic ultrasound for the diagnosis and staging of liver tumors[J]. Gastrointest Endosc Clin N Am, 2019, 29(2): 339-350. DOI: 10.1016/j.giec.2018.12.005.
    [7]
    BEYER LP, WASSERMANN F, PREGLER B, et al. Characterization of focal liver lesions using CEUS and MRI with liver-specific contrast media: Experience of a single radiologic center[J]. Ultraschall Med, 2017, 38(6): 619-625. DOI: 10.1055/s-0043-105264.
    [8]
    OH D, SEO DW, HONG SM, et al. The usefulness of contrast-enhanced harmonic EUS-guided fine-needle aspiration for evaluation of hepatic lesions (with video)[J]. Gastrointest Endosc, 2018, 88(3): 495-501. DOI: 10.1016/j.gie.2018.05.019.
    [9]
    MINAGA K, KITANO M, NAKAI A, et al. Improved detection of liver metastasis using Kupffer-phase imaging in contrast-enhanced harmonic EUS in patients with pancreatic cancer (with video)[J]. Gastrointest Endosc, 2021, 93(2): 433-441. DOI: 10.1016/j.gie.2020.06.051.
    [10]
    JOHNSON KD, LAOVEERAVAT P, YEE EU, et al. Endoscopic ultrasound guided liver biopsy: Recent evidence[J]. World J Gastrointest Endosc, 2020, 12(3): 83-97. DOI: 10.4253/wjge.v12.i3.83.
    [11]
    SHUJA A, ALKHASAWNEH A, FIALHO A, et al. Comparison of EUS-guided versus percutaneous and transjugular approaches for the performance of liver biopsies[J]. Dig Liver Dis, 2019, 51(6): 826-830. DOI: 10.1016/j.dld.2019.01.006.
    [12]
    ALI AH, PANCHAL S, RAO DS, et al. The efficacy and safety of endoscopic ultrasound-guided liver biopsy versus percutaneous liver biopsy in patients with chronic liver disease: A retrospective single-center study[J]. J Ultrasound, 2020, 23(2): 157-167. DOI: 10.1007/s40477-020-00436-z.
    [13]
    BHATIA V, VARADARAJULU S. Endoscopic ultrasonography-guided tissue acquisition: How to achieve excellence[J]. Dig Endosc, 2017, 29(4): 417-430. DOI: 10.1111/den.12823.
    [14]
    NGUYEN P, FENG JC, CHANG KJ. Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions[J]. Gastrointest Endosc, 1999, 50(3): 357-361. DOI: 10.1053/ge.1999.v50.97208.
    [15]
    OH D, SEO DW, HONG SM, et al. Endoscopic ultrasound-guided fine-needle aspiration can target right liver mass[J]. Endosc Ultrasound, 2017, 6(2): 109-115. DOI: 10.4103/2303-9027.204813.
    [16]
    CHON HK, YANG HC, CHOI KH, et al. Endoscopic ultrasound-guided liver biopsy using a core needle for hepatic solid mass[J]. Clin Endosc, 2019, 52(4): 340-346. DOI: 10.5946/ce.2018.175.
    [17]
    CHEN F, BAO H, DENG Z, et al. Endoscopic ultrasound-guided sampling using core biopsy needle for diagnosis of left-lobe hepatocellular carcinoma in patients with underlying cirrhosis[J]. J Cancer Res Ther, 2020, 16(5): 1100-1105. DOI: 10.4103/jcrt.JCRT_723_19.
    [18]
    SCHULMAN AR, THOMPSON CC, ODZE R, et al. Optimizing EUS-guided liver biopsy sampling: Comprehensive assessment of needle types and tissue acquisition techniques[J]. Gastrointest Endosc, 2017, 85(2): 419-426. DOI: 10.1016/j.gie.2016.07.065.
    [19]
    CHING-COMPANIONI RA, DIEHL DL, JOHAL AS, et al. 19 G aspiration needle versus 19 G core biopsy needle for endoscopic ultrasound-guided liver biopsy: A prospective randomized trial[J]. Endoscopy, 2019, 51(11): 1059-1065. DOI: 10.1055/a-0956-6922.
    [20]
    MOHAN BP, SHAKHATREH M, GARG R, et al. Efficacy and safety of EUS-guided liver biopsy: A systematic review and meta-analysis[J]. Gastrointest Endosc, 2019, 89(2): 238-246. DOI: 10.1016/j.gie.2018.10.018.
    [21]
    RUSTEMOVIC N, HRSTIC I, OPACIC M, et al. EUS elastography in the diagnosis of focal liver lesions[J]. Gastrointest Endosc, 2007, 66(4): 823-824; discussion 824. DOI: 10.1016/j.gie.2007.06.047.
    [22]
    European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis[J]. J Hepatol, 2015, 63(1): 237-264. DOI: 10.1016/j.jhep.2015.04.006.
    [23]
    SANDULESCU L, PADUREANU V, DUMITRESCU C, et al. A pilot study of real time elastography in the differentiation of focal liver lesions[J]. Curr Health Sci J, 2012, 38(1): 32-35.
    [24]
    MA X, ZHAN W, ZHANG B, et al. Elastography for the differentiation of benign and malignant liver lesions: A meta-analysis[J]. Tumour Biol, 2014, 35(5): 4489-4497. DOI: 10.1007/s13277-013-1591-4.
    [25]
    JIAO Y, DONG F, WANG H, et al. Shear wave elastography imaging for detecting malignant lesions of the liver: A systematic review and pooled meta-analysis[J]. Med Ultrason, 2017, 19(1): 16-22. DOI: 10.11152/mu-925.
    [26]
    HU X, HUANG X, CHEN H, et al. Diagnostic effect of shear wave elastography imaging for differentiation of malignant liver lesions: A meta-analysis[J]. BMC Gastroenterol, 2019, 19(1): 60. DOI: 10.1186/s12876-019-0976-2.
    [27]
    SCOPELLITI F, PEA A, CONIGLIARO R, et al. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer[J]. Surg Endosc, 2018, 32(9): 4022-4028. DOI: 10.1007/s00464-018-6217-x.
    [28]
    DHALIWAL A, KOLLI S, DHINDSA BS, et al. Efficacy of EUS-RFA in pancreatic tumors: Is it ready for prime time? A systematic review and meta-analysis[J]. Endosc Int Open, 2020, 8(10): e1243-e1251. DOI: 10.1055/a-1221-5012.
    [29]
    de NUCCI G, DELLA CORTE C, REATI R, et al. Endoscopic ultrasound-guided radiofrequency ablation for hepatocellular carcinoma in cirrhosis: A case report test for efficacy and future perspectives[J]. Endosc Int Open, 2020, 8(11): e1713-e1716. DOI: 10.1055/a-1236-3105.
    [30]
    LUCCHINA N, TSETIS D, IERARDI AM, et al. Current role of microwave ablation in the treatment of small hepatocellular carcinomas[J]. Ann Gastroenterol, 2016, 29(4): 460-465. DOI: 10.20524/aog.2016.0066.
    [31]
    CHUA T, FAIGEL DO. Endoscopic ultrasound-guided ablation of liver tumors[J]. Gastrointest Endosc Clin N Am, 2019, 29(2): 369-379. DOI: 10.1016/j.giec.2018.11.007.
    [32]
    LU J, ZHU HD, TENG GJ, et al. Role of interventional therapy in the downstaging of advanced liver cancer[J]. J Clin Hepatol, 2020, 36(2): 272-276. DOI: 10.3969/j.issn.1001-5256.2020.02.006.

    陆建, 朱海东, 滕皋军, 等. 介入治疗在中晚期肝癌降期中的作用[J]. 临床肝胆病杂志, 2020, 36(2): 272-276. DOI: 10.3969/j.issn.1001-5256.2020.02.006.
    [33]
    WEIS S, FRANKE A, BERG T, et al. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma[J]. Cochrane Database Syst Rev, 2015, 1: CD006745. DOI: 10.1002/14651858.CD006745.pub3.
    [34]
    CHOI JH, PARK DH, KIM MH, et al. Outcomes after endoscopic ultrasound-guided ethanol-lipiodol ablation of small pancreatic neuroendocrine tumors[J]. Dig Endosc, 2018, 30(5): 652-658. DOI: 10.1111/den.13058.
    [35]
    TEOH AY, CHONG CC, CHAN AW, et al. EUS-guided alcohol injection of pancreatic neuroendocrine tumor[J]. Gastrointest Endosc, 2015, 82(1): 167. DOI: 10.1016/j.gie.2015.01.047.
    [36]
    XU ZF, XIE XY, CUI Y, et al. Initial clinical experience of ethanol ablation with endoscopic ultrasonography guidance for 10 cases of hepatocellular carcinoma which are difficult to reach by percutaneous mode[J/CD]. Chin J Med Ultrasound (Electronic edition), 2011, 8(9): 1964-1969. DOI: 10.3877/cma.j.issn.1672-6448.2011.09.015.

    徐作峰, 谢晓燕, 崔毅, 等. 超声内镜引导无水酒精治疗特殊部位肝癌10例[J/CD]. 中华医学超声杂志(电子版), 2011, 8(9): 1964-1969. DOI: 10.3877/cma.j.issn.1672-6448.2011.09.015.
    [37]
    NAKAJI S, HIRATA N, KOBAYASHI M, et al. Endoscopic ultrasonography-guided ethanol injection as a treatment for ruptured hepatocellular carcinoma in the left hepatic lobe[J]. Endoscopy, 2015, 47 Suppl 1: e558-e560. DOI: 10.1055/s-0034-1393394.
    [38]
    NAKAJI S, HIRATA N, MIKATA R, et al. Clinical outcomes of endoscopic ultrasound-guided ethanol injection for hepatocellular carcinoma in the caudate lobe[J]. Endosc Int Open, 2016, 4(10): e1111-e1115. DOI: 10.1055/s-0042-116146.
    [39]
    SEO DW. EUS-guided antitumor therapy for pancreatic tumors[J]. Gut Liver, 2010, 4 Suppl 1: s76-s81. DOI: 10.5009/gnl.2010.4.S1.S76.
    [40]
    LEVY MJ, ALBERTS SR, BAMLET WR, et al. EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer[J]. Gastrointest Endosc, 2017, 86(1): 161-169. DOI: 10.1016/j.gie.2016.11.014.
    [41]
    POGGI G, TOSORATTI N, MONTAGNA B, et al. Microwave ablation of hepatocellular carcinoma[J]. World J Hepatol, 2015, 7(25): 2578-2589. DOI: 10.4254/wjh.v7.i25.2578.
    [42]
    DING J, JING X, LIU J, et al. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma[J]. Eur J Radiol, 2013, 82(9): 1379-1384. DOI: 10.1016/j.ejrad.2013.04.025.
    [43]
    SHI J, SUN Q, WANG Y, et al. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria[J]. J Gastroenterol Hepatol, 2014, 29(7): 1500-1507. DOI: 10.1111/jgh.12572.
    [44]
    SONG SY, ZHANG S, LIU F, et al. An experimental study on endoscopic ultrasound-guided microwave ablation for porcine liver and pancreas[J]. Chin J Dig Endosc, 2019, 36(2): 119-123. DOI: 10.3760/cma.j.issn.1007-5232.2019.02.008.

    宋世义, 张松, 刘飞, 等. 内镜超声引导下微波消融猪肝脏及胰腺的实验研究[J]. 中华消化内镜杂志, 2019, 36(2): 119-123. DOI: 10.3760/cma.j.issn.1007-5232.2019.02.008.
    [45]
    JI J, SHI J, BUDHU A, et al. MicroRNA expression, survival, and response to interferon in liver cancer[J]. N Engl J Med, 2009, 361(15): 1437-1447. DOI: 10.1056/NEJMoa0901282.
    [46]
    CAMPOS S, POLEY JW, van DRIEL L, et al. The role of EUS in diagnosis and treatment of liver disorders[J]. Endosc Int Open, 2019, 7(10): e1262-e1275. DOI: 10.1055/a-0958-2183.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (616) PDF downloads(45) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return